Discontinued — last reported Q4 '25
Investing
Other Investing
Eli Lilly Other Investing increased by 154.6% to $31.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 127.9%, from -$111.00M to $31.00M. Over 2 years (FY 2021 to FY 2025), Other Investing shows a downward trend with a -92.8% CAGR.
Analysis
StatementCash Flow Statement
SectionInvesting
CategoryOther
SignalContext dependent
VolatilityStable
First reportedQ1 2013
Last reportedQ4 2025
How to read this metric
Generally neutral, but large fluctuations may indicate non-recurring events or specific financial adjustments that warrant further investigation.
Detailed definition
This metric aggregates miscellaneous cash inflows and outflows related to investing activities that do not fit into stan...
Peer comparison
Usually a small component of total investing cash flow; peers report similar miscellaneous items based on specific accounting treatments.
Metric ID:
other_investingHistorical Data
17 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$72.40M | $53.20M | $189.00M | $133.40M | $222.80M | -$40.30M | -$456.80M | $666.20M | $48.20M | -$105.20M | -$373.20M | $678.20M | -$111.00M | $135.80M | $31.00M | -$56.80M | $31.00M |
| QoQ Change | — | +173.5% | +255.3% | -29.4% | +67.0% | -118.1% | <-999% | +245.8% | -92.8% | -318.3% | -254.8% | +281.7% | -116.4% | +222.3% | -77.2% | -283.2% | +154.6% |
| YoY Change | — | — | — | — | +318.8% | -130.2% | — | +199.0% | +219.6% | +77.0% | -156.0% | — | -330.3% | +229.1% | +108.3% | -108.4% | +127.9% |
Range-$456.80M – $678.20M
CAGR-19.1%
Avg YoY Growth+50.4%
Median YoY Growth+108.3%
Other Investing at Other Companies
Frequently Asked Questions
- What is Eli Lilly's other investing?
- Eli Lilly (LLY) reported other investing of $31.00M in Q1 2026.
- How has Eli Lilly's other investing changed year-over-year?
- Eli Lilly's other investing increased by 127.9% year-over-year, from -$111.00M to $31.00M.
- What is the long-term trend for Eli Lilly's other investing?
- Over 2 years (2021 to 2025), Eli Lilly's other investing has grown at a -92.8% compound annual growth rate (CAGR), from $191.70M to -$1.00M.
- What does other investing mean?
- Miscellaneous cash flows related to investing that are not categorized elsewhere.